All posts
14550 total · page 32 of 291
Global Nursing Education Conference Highlights Innovative Practices
The 8th International Conference on Nursing Education and Healthcare showcases advancements in nursing practices and education strategies.
Molbio Diagnostics IPO Eyes Growth Amid Tuberculosis Test Success
Molbio Diagnostics plans to raise ₹200 crore for expansion and reduce promoter stake through its IPO. Focused on tuberculosis test kits, it targets high-risk investors.
Docon Technologies Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies has divested a 9.9% stake in Thyrocare Technologies, raising Rs 986 crore through various deals.
Expert Warns Against Overreliance on Smartwatches for Heart Health
A cardiologist cautions that smartwatches, while useful, have limitations in assessing heart health and shouldn't replace medical advice.
Alzheimer’s Biomarkers Linked to Early Motor Decline
Research highlights a connection between Alzheimer’s biomarkers and early motor decline, suggesting new pathways for intervention.
Experts Warn Against Sacrificing Sleep for Career Success
Health professionals caution that neglecting sleep for work could lead to severe health issues, including early ICU admissions.
Surrogate Birth Sparks Legal Battle Over Child Custody
A surrogate gave birth in Texas amid a legal dispute after biological parents requested termination at 20 weeks.
India's Medical Device Industry Challenges Draft Bill's Pharma Approach
India's medical device sector opposes a draft bill equating devices with drugs, fearing harm to innovation and investment.
Abhay Soi Critiques Proposed Price Cap on Private Hospitals
Max Healthcare's Abhay Soi warns against a blanket price cap, citing investment concerns.
Molbio Diagnostics Aims for ₹200 Crore with IPO Amid Global Expansion
Molbio Diagnostics plans a ₹200 crore IPO to fund growth and reduce promoter stake. The firm targets high-risk investors with its strong revenue from TB test kits.
Docon Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon offloads a 9.9% stake in Thyrocare Technologies, reducing its holding to just over 51%.
Surrogate Fights for Custody After Birth Amid Dispute with Parents
A surrogate mother in Texas is battling for custody after giving birth to a baby diagnosed with a heart defect.
Medical Device Industry Opposes Draft Bill Treating Devices as Drugs
India's medical device sector criticizes the Draft Bill, arguing it equates devices to drugs, potentially stifling innovation and investment.
Abhay Soi Criticizes Proposed Price Cap for Private Hospitals
Abhay Soi of Max Healthcare questions the viability of a proposed price cap on private hospital rooms, citing investment concerns.
Molbio Diagnostics Targets ₹940 Crore in IPO Amid Global Expansion
Molbio Diagnostics plans a ₹940 crore IPO to expand its operations and reduce promoter stake, leveraging success in TB diagnostics.
Docon Technologies Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies reduced its stake in Thyrocare Technologies to 51.02% by selling 9.9% for Rs 986 crore.
Surrogate Flees to Texas Amid Legal Battle Over Baby's Custody
A surrogate birth sparks a legal fight after the biological parents demanded an abortion.
Medical Device Industry Opposes Draft Bill Treating Devices as Drugs
India's medical device sector opposes a draft bill equating devices with pharmaceuticals, fearing it will harm innovation and investment.
Abhay Soi Critiques Proposed Price Cap on Private Hospital Rooms
Abhay Soi questions a parliamentary panel's proposal to cap private hospital room rents, citing investment challenges.
Molbio Diagnostics Seeks ₹940 Crore in IPO for Expansion and Stake Reduction
Molbio Diagnostics plans a ₹940 crore IPO to fund expansion and reduce promoter stake, amid strong revenue growth from its tuberculosis test kits.
Docon Sells 9.9% Thyrocare Stake for Rs 986 Crore Amid Investor Interest
Docon Technologies offloads 9.9% stake in Thyrocare for Rs 986 crore, attracting major institutional investors.
Texas Surrogate Birth Amidst Legal Battle Over Baby's Custody
A surrogate gave birth in Texas after a dispute with the biological parents who sought to terminate the pregnancy.
Industry Pushback: Medical Devices Not Pharma, Companies Argue
Medical device firms challenge a draft bill equating devices with drugs, fearing impacts on innovation and investment.
Abhay Soi Criticizes Proposed Price Cap on Private Hospital Rooms
Max Healthcare's Abhay Soi argues against a blanket price cap, citing investment needs.
Molbio Diagnostics Aims ₹940 Crore from IPO for Growth and Expansion
Molbio Diagnostics plans to raise ₹200 crore for capital expenses and ₹740 crore via an offer for sale, reducing promoter stake to 43%.
Docon Sells 9.9% Thyrocare Stake for Rs 986 Crore in Major Deal
Docon Technologies divests a 9.9% stake in Thyrocare Technologies for Rs 986 crore through bulk and block deals on NSE and BSE.
Surrogate Birth Triggers Legal Battle Over Child Custody
A surrogate gave birth in Texas amid a custody battle with the biological parents who had sought to terminate the pregnancy.
Medical Device Industry Opposes Draft Bill Treating Devices as Drugs
India's medical device sector challenges a draft bill equating devices with pharmaceuticals, citing potential harm to innovation and investment.
Abhay Soi Challenges Proposed Price Cap on Private Hospital Rooms
Max Healthcare's Abhay Soi argues against a blanket price cap on private hospital rooms, emphasizing investment needs.
Molbio Diagnostics IPO Seeks Growth with ₹940 Crore Fundraising Plan
Molbio Diagnostics aims to raise ₹940 crore through an IPO to fund expansion and reduce promoter stake.
Docon Sells 9.9% Thyrocare Stake for Rs 986 Crore Amid Strong Investor Interest
Docon Technologies has sold a 9.9% stake in Thyrocare Technologies for Rs 986 crore through bulk and block deals, reducing its ownership to 51.02%.
Surrogate Birth Sparks Legal Battle with Biological Parents
A surrogate mother is in a legal battle after giving birth to a baby diagnosed with a heart defect.
Medical Device Industry Rebukes Draft Bill for Pharma-Like Regulations
India's medical device sector opposes a draft bill equating devices with pharmaceuticals, fearing it may stifle growth and innovation.
Max Healthcare's Abhay Soi Criticizes Proposed Hospital Room Price Cap
Abhay Soi of Max Healthcare argues against a price cap on hospital rooms, citing the need for investment.
Molbio Diagnostics IPO Targets ₹200 Crore for Expansion
Molbio Diagnostics plans to raise ₹200 crore and reduce promoter stake with its IPO, appealing to high-risk investors.
Docon Technologies Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies has sold a 9.9% stake in Thyrocare Technologies for Rs 986 crore, reducing its holding to 51.02%.
Surrogate Birth Triggers Legal Battle Over Parental Rights
A surrogate gave birth in Texas amid a dispute with the biological parents over a pregnancy termination request.
Medical Device Industry Challenges India's Draft Regulatory Bill
India's medical device sector criticizes a draft bill equating devices with pharma, warning it could stifle growth.
Abhay Soi Critiques Price Cap on Private Hospital Rooms
Max Healthcare's Abhay Soi challenges a proposed price cap, stressing investment needs.
Molbio Diagnostics Targets ₹940 Crore in IPO to Fuel Global Expansion
Molbio Diagnostics seeks to raise ₹940 crore through its IPO, aiming to enhance capital expenditures and reduce promoter stake.
Docon Sells 9.9% Stake in Thyrocare for Rs 986 Crore to Investors
Docon Technologies divests 9.9% stake in Thyrocare, raising Rs 986 crore through NSE and BSE deals.
Surrogate Defies Parents' Wishes, Sparks Legal Battle Over Baby
A surrogate gave birth in Texas amid a legal dispute after the biological parents requested to terminate the pregnancy.
Medical Device Industry Opposes Draft Bill Treating Devices as Drugs
India's medical device sector protests the draft bill equating devices with pharmaceuticals, citing potential harm to innovation and investment.
Abhay Soi Questions Price Cap on Private Hospital Rooms
Max Healthcare's Abhay Soi argues against a uniform price cap on hospital rooms, citing investment and expansion concerns.
Molbio Diagnostics IPO: A High-Stakes Opportunity for Investors
Molbio Diagnostics aims to raise ₹200 crore for expansion and cut promoter stake with a ₹740 crore offer for sale, targeting high-risk investors.
Docon Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies has sold a 9.9% stake in Thyrocare, reducing its holding to 51.02%.
Surrogate in Texas Births Baby Amid Legal Battle Over Heart Defect
A surrogate mother and biological parents face legal conflict after a Texas birth involving a baby diagnosed with a heart defect.
Medical Device Industry Challenges Draft Bill's Pharma Approach
India's medical device industry opposes a draft bill treating devices like drugs, citing risks to innovation and investment.
Abhay Soi Challenges Proposed Price Caps on Hospital Rooms
Max Healthcare's Abhay Soi questions a Parliamentary proposal to cap private hospital room rates, citing investment concerns.
Molbio Diagnostics' ₹940 Crore IPO Targets Growth Amidst Global Expansion
Molbio Diagnostics plans a ₹940 crore IPO to fund expansion and reduce promoter stakes, aiming for growth in the global diagnostics market.